Filing Details
- Accession Number:
- 0001209191-18-037138
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-12 07:40:15
- Reporting Period:
- 2018-06-08
- Accepted Time:
- 2018-06-12 07:40:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360928 | M Lauren Sabella | 420 Saw Mill River Road Ardsley NY 10502 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-08 | 24,375 | $16.50 | 35,540 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-08 | 24,375 | $35.00 | 11,165 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-06-08 | 24,375 | $0.00 | 24,375 | $16.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,625 | 2027-05-01 | No | 4 | M | Direct |
Footnotes
- Exercise and sale pursuant to a 10b5-1 plan.
- The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% having vested at the end of six monthsafter the grant date and the remaining 75% vesting in equal quarterly installments over the remainder of such two year period.
Billionaire Hedge Funds
